Reboot On Diabetic Nephropathy Measure Efforts
July 18th, 2019 | ArchiveAs a network, AHP has fallen in our performance on the Medical Attention for Nephropathy metric. However, we are extremely close to reaching the 90th percentile; there are less than 500 patients across all practices that need gap closures to get us there.
As a reminder the definition for this measure is as follows: The percentage of patients 18–75 years of age with diabetes (type 1 and type 2) with a nephropathy screening test or evidence of nephropathy, defined as evidence of treatment for nephropathy, evidence of a visit to a nephrologist, a micro albumin test, an ACEI, ARB, or a positive macro albumin test in the measurement year.
In the coming weeks we will be reaching out to engage practice in efforts to improve our performance on this measure. We would like to support your work in this measure by offering best practices and providing actionable data that will drive positive results. Please reach out to Melissa Claybaugh with questions.
